Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications.

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Weight loss jabs are not a “holy grail” and will not solve the obesity crisis on their own, England’s top doctor has said.

For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...

New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said. Sir Keir Starmer said that the anti-obesity medication could also help ...

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...